Cautiously bullish on Ucore Rare Metals Inc. as a REE trading play—upside from U.S. policy/Greenland headlines and some ...
FY 2025 Preliminary Unaudited Total Revenue of Approximately $510--511 Million Meets or Exceeds Prior Guidance Previously Provided FY 2025 Adjusted EBITDA (1) and Adjusted Net Income (2) Guidance ...
PTC Therapeutics, Inc. (NASDAQ: PTCT) today provided an update on the Company's progress and its outlook for 2026. Matthew B. Klein, M.D., Chief Executive Officer of PTC, will discuss these updates at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback